Biopharmaceutical Contract Manufacturing Market 2021: Size, Industry Growth, COVID-19 Impact, Insights, Trends, Share and Forecast to 2029 | Lonza Group AG, Baxter Biopharma Solutions, Samsung Biologics Co., Ltd.
A new study on the global biopharmaceutical contract manufacturing market by FMI discusses some interesting aspects of the differentiating strategies of key market players. Top biomanufacturing companies in North America and Europe are focussing on market collaborations and agreements as key business strategies for growth and expansion across the globe. These companies are also acquiring small scale biopharmaceuticals companies in the Asia Pacific region to strengthen their market presence. FMI presents several useful insights and a comprehensive revenue forecast of the global biopharmaceutical contract manufacturing market in a new report titled “Biopharmaceutical Contract Manufacturing Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027” along with information on the factors influencing revenue growth of the market over a 10 year assessment period from 2017 to 2027.
The global biopharmaceutical contract manufacturing market is estimated to be valued at US$ 5,625.0 Mn by the end of 2017 and this is expected to increase to US$ 15,467.8 Mn by the end of 2027, registering a CAGR of 10.6% in terms of value over the forecast period.
Global Market Research Report Overview on Biopharmaceutical Contract Manufacturing@ https://www.futuremarketinsights.com/reports/biopharmaceutical-contract-manufacturing-market
Global Biopharmaceutical Contract Manufacturing Market: Regional Forecast
The global biopharmaceutical contract manufacturing market has been studied across the key regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is the largest regional market, estimated to be valued at US$ 5,039.3 Mn by 2027 end, with a CAGR of 9.8%. APEJ is the second largest market for biopharmaceutical contract manufacturing, with a growth rate of 12.2% anticipated during the 10 year forecast period.
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Platform
The report segments the global biopharmaceutical contract manufacturing market on the basis of Platform into Mammalian and Microbial. Mammalian is the largest segment by platform, which is estimated to represent US$ 3,857.2 Mn or 68.6% share of the total market in 2017 and is projected to reach US$ 12,534.5 Mn or 81.0% share by 2027 end, expanding at a CAGR of 12.5% over the forecast period.
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Product Type
In terms of product type, the global biopharmaceutical contract manufacturing market is segmented into Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, and Others. Monoclonal Antibodies is the largest segment by product type, with revenues estimated to cross US$ 8,100 Mn by the end of the forecast period and a CAGR of 11.3%.
View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/biopharmaceutical-contract-manufacturing-market/toc
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Application
The global biopharmaceutical contract manufacturing market is segmented on the basis of application into Clinical and Commercial. The Commercial segment will dominate the global market, with revenues in excess of US$ 12,000 Mn expected to be recorded by the end of 2027 resulting in a CAGR of 11.0%.
Global Biopharmaceutical Contract Manufacturing Market: Forecast by Therapeutic Area
On the basis of therapeutic area, the global biopharmaceutical contract manufacturing market is segmented into Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, and Others. Oncology is the largest segment by therapeutic area, expected to be valued at US$ 1,111.1 Mn by the end of 2017. Oncology is also the most lucrative segment. Autoimmune Diseases is the second largest segment by therapeutic area with a market attractiveness index of 1.3.
Global Biopharmaceutical Contract Manufacturing Market: Competitive Landscape
The report features some of the leading companies operating in the global biopharmaceutical contract manufacturing market. Companies profiled include Lonza Group AG, Baxter Biopharma Solutions, Samsung Biologics Co., Ltd., Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim GmbH, Patheon N.V., Rentschler Biotechnologie GmbH, Biomeva GmbH, Probiogen AG, Cytovance Biologics, Inc., KBI Biopharma, Inc., WuXi Biologics, Abzena Plc, Vetter Pharma International GmbH, Sandoz International GmbH, Catalent, Inc., AbbVie Contract Manufacturing (An AbbVie Company), Ajinomoto Althea, Inc.
Table Of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. Analysis and Recommendations
A sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2982
2. Market Introduction
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
4. Global Biopharmaceutical Contract Manufacturing Market Analysis 2014-2018 and Opportunity Assessment, 2019-2029
5. Global Biopharmaceutical Contract Manufacturing Market Analysis 2014-2018 and Forecast 2019-2029, by Platform
6. Global Biopharmaceutical Contract Manufacturing Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
7. Global Biopharmaceutical Contract Manufacturing Market Analysis 2014-2018 and Forecast 2019-2029, by Application
And So On…
Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape
Mammalian Derived Proteins Market FMI’s analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region.
Prokaryotic Recombinant Protein Market Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region.
Toe Fixation System Market FMI’s report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com